These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7886778)

  • 1. Comparison of glucose versus fat emulsion in the preparation of amphotericin B for use in kala-azar.
    Thakur CP
    Trans R Soc Trop Med Hyg; 1994; 88(6):698-9. PubMed ID: 7886778
    [No Abstract]   [Full Text] [Related]  

  • 2. Amphotericin B--fat emulsion in treatment of visceral leishmaniasis--a cost effective substitute for liposomal amphotericin B.
    Singh GP; Saxena RK; Priyadarshy V
    J Indian Med Assoc; 2010 Jan; 108(1):27-8. PubMed ID: 20839576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of visceral leishmaniasis with high-dose amphotericin B diluted in fat emulsion: a case report.
    Herbrecht R; Sosa C; Himy R; Villard O
    Trans R Soc Trop Med Hyg; 1996; 90(3):322-3. PubMed ID: 8758094
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety and efficacy of Intralipid emulsions of amphotericin B.
    Herbrecht R; Letscher V
    J Antimicrob Chemother; 1997 Jul; 40(1):137-9. PubMed ID: 9249219
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety of a pre-formulated amphotericin B lipid emulsion for the treatment of Indian Kala-azar.
    Sundar S; Chakravarty J; Agarwal D; Shah A; Agrawal N; Rai M
    Trop Med Int Health; 2008 Sep; 13(9):1208-12. PubMed ID: 18664241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphotericin B therapy in kala-azar.
    Giri OP
    J Indian Med Assoc; 1993 Apr; 91(4):91-3. PubMed ID: 8409490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative cardiac toxicity of sodium stibogluconate and amphotericin B in treatment of kala-azar.
    Maheshwari A; Seth A; Kaur S; Aneja S; Rath B; Basu S; Patel R; Dutta AK
    Pediatr Infect Dis J; 2011 Feb; 30(2):180-1. PubMed ID: 20823781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily versus alternate-day regimen of amphotericin B in the treatment of kala-azar: a randomized comparison.
    Thakur CP; Sinha GP; Pandey AK; Barat D; Singh RK
    Bull World Health Organ; 1994; 72(6):931-6. PubMed ID: 7867139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and toxicity of amphotericin B in glucose 5% or intralipid 20% in neutropenic patients with pneumonia or fever of unknown origin: randomised study.
    Schöffski P; Freund M; Wunder R; Petersen D; Köhne CH; Hecker H; Schubert U; Ganser A
    BMJ; 1998 Aug; 317(7155):379-84. PubMed ID: 9694753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Indian Kala-azar with pentavalent antimony.
    Domingo P; Ferrer S; Kolle L; Muñoz C; Sambeat MA
    Lancet; 1995 Mar; 345(8949):584-5. PubMed ID: 7776793
    [No Abstract]   [Full Text] [Related]  

  • 11. Study the effects of PLGA-PEG encapsulated amphotericin B nanoparticle drug delivery system against Leishmania donovani.
    Kumar R; Sahoo GC; Pandey K; Das V; Das P
    Drug Deliv; 2015 May; 22(3):383-8. PubMed ID: 24601828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphotericin B deoxycholate for relapse visceral leishmaniasis in Bangladesh: a cross-sectional study.
    Hasnain MG; Nath P; Maruf S; Nabi SG; Hossain AFMA; Ahmed BN; Mondal D; Basher A
    BMC Res Notes; 2018 Dec; 11(1):918. PubMed ID: 30577877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of high-dose infusions of a preformed amphotericin B fat emulsion for treatment of Indian visceral leishmaniasis.
    Sundar S; Singh A; Agarwal D; Rai M; Agrawal N; Chakravarty J
    Am J Trop Med Hyg; 2009 May; 80(5):700-3. PubMed ID: 19407109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphotericin B does not mix with fat emulsion.
    Trissel LA
    Am J Health Syst Pharm; 1995 Jul; 52(13):1463-4. PubMed ID: 7671046
    [No Abstract]   [Full Text] [Related]  

  • 15. Amphotericin B in resistant kala-azar in Bihar.
    Thakur CP; Sinha GP; Pandey AK; Barat D; Sinha PK
    Natl Med J India; 1993; 6(2):57-60. PubMed ID: 8477209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Brazilian kala-azar with a short course of amphocil (amphotericin B cholesterol dispersion).
    Dietze R; Milan EP; Berman JD; Grogl M; Falqueto A; Feitosa TF; Luz KG; Suassuna FA; Marinho LA; Ksionski G
    Clin Infect Dis; 1993 Dec; 17(6):981-6. PubMed ID: 8110956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India.
    Thakur CP; Kumar A; Mitra G; Thakur S; Sinha PK; Das P; Bhattacharya SK; Sinha A
    Indian J Med Res; 2008 Jul; 128(1):38-44. PubMed ID: 18820357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme.
    Hossain MS; Kumar A; Hossain AFMA; Mahshin M; Sharma A; Hossain MA; Sharma V; Haque R; Shamsuzzaman AKM; Maruf S; Ghosh P; Ahuja V; Mondal D
    Infect Dis Poverty; 2018 Aug; 7(1):80. PubMed ID: 30099967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three treatment regimens with liposomal amphotericin B (AmBisome) for visceral leishmaniasis in India: a randomized dose-finding study.
    Thakur CP; Pandey AK; Sinha GP; Roy S; Behbehani K; Olliaro P
    Trans R Soc Trop Med Hyg; 1996; 90(3):319-22. PubMed ID: 8758093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction of serum electrolyte imbalance prevents cardiac arrhythmia during amphotericin B administration.
    Thakur CP
    Natl Med J India; 1995; 8(1):13-4. PubMed ID: 7696938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.